Skip to main content

Total Hip Replacement

1
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Stryker
StrykerCA - San Jose
1 program
1
Secure-Fit™ arc-deposited HydroxylapatitePhase 41 trial
Active Trials
NCT01522014Completed92Est. Jun 2009
Medacta
MedactaSwitzerland - Castel San Pietro
2 programs
Mpact Cup Performance After Total Hip ArthroplastyN/A1 trial
Mpact Double Mobility cupN/A1 trial
Active Trials
NCT02846636Suspended100Est. Apr 2029
NCT02850575Active Not Recruiting150Est. Jan 2030
Ortho Development
1 program
Total Hip ArthroplastyN/A1 trial
Active Trials
NCT04277416Enrolling By Invitation250Est. Dec 2032
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Total Hip ArthroplastyN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
StrykerSecure-Fit™ arc-deposited Hydroxylapatite
Ortho DevelopmentTotal Hip Arthroplasty
MedactaMpact Cup Performance After Total Hip Arthroplasty
MedactaMpact Double Mobility cup

Clinical Trials (4)

Total enrollment: 592 patients across 4 trials

NCT01522014StrykerSecure-Fit™ arc-deposited Hydroxylapatite

Randomized Clinical Trial of Ceramic Bearing Primary Total Hip Arthroplasty

Start: Nov 1997Est. completion: Jun 200992 patients
Phase 4Completed
NCT04277416Ortho DevelopmentTotal Hip Arthroplasty

Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty

Start: Feb 2020Est. completion: Dec 2032250 patients
N/AEnrolling By Invitation
NCT02846636MedactaMpact Cup Performance After Total Hip Arthroplasty

Mpact Cup Performance After Total Hip Arthroplasty

Start: Aug 2014Est. completion: Apr 2029100 patients
N/ASuspended
NCT02850575MedactaMpact Double Mobility cup

Bone Fixation of Mpact Double Mobility Cup

Start: Jan 2014Est. completion: Jan 2030150 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.